Pituitary disease: presentation, diagnosis, and management.
作者信息
Levy A
机构信息
Henry Wellcome Labs for Integrative Neuroscience and Endocrinology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK.
出版信息
J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3(Suppl 3):iii47-52. doi: 10.1136/jnnp.2004.045740.
Abstract
摘要
相似文献
1
Pituitary disease: presentation, diagnosis, and management.垂体疾病：临床表现、诊断与管理
J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3(Suppl 3):iii47-52. doi: 10.1136/jnnp.2004.045740.
2
Treatment of patients with a pituitary adenoma: one clinician's experience.垂体腺瘤患者的治疗：一位临床医生的经验
Neurosurg Focus. 2004 Apr 15;16(4):E1. doi: 10.3171/foc.2004.16.4.2.
3
Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.催乳素瘤和无功能垂体腺瘤的诊断与管理
BMJ. 2014 Sep 10;349:g5390. doi: 10.1136/bmj.g5390.
4
Diagnosis and management of hormone-secreting pituitary adenomas.分泌激素垂体腺瘤的诊断与管理
N Engl J Med. 1991 Mar 21;324(12):822-31. doi: 10.1056/NEJM199103213241207.
5
[New developments in pituitary diseases].[垂体疾病的新进展]
Dtsch Med Wochenschr. 2012 Dec;137(49):2540-2. doi: 10.1055/s-0032-1327285. Epub 2012 Nov 27.
6
Twelve cases of pituitary apoplexy.12例垂体卒中。
Arch Intern Med. 1992 Sep;152(9):1893-9.
7
[Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma].[垂体功能亢进的治疗：从肢端肥大症到泌乳素瘤]
Internist (Berl). 2006 Dec;47(12):1215-6, 1218-20, 1222. doi: 10.1007/s00108-006-1727-3.
8
Diagnosis and management of pituitary tumors.垂体肿瘤的诊断与管理
Med Sect Proc. 1994:167-78.
9
The evaluation and management of subclinical pituitary disease.亚临床垂体疾病的评估与管理
Postgrad Med J. 1996 May;72(847):258-62. doi: 10.1136/pgmj.72.847.258.
10
[Prolactinoma and acromegaly. What can medication do, when must the surgeon be consulted?].[泌乳素瘤和肢端肥大症。药物能起到什么作用，何时必须咨询外科医生？]
MMW Fortschr Med. 2006 Jan 19;148(3):12-3.
引用本文的文献
1
ANAESTHESIA FOR ENDOSCOPIC ENDONASAL TRANSPHENOIDAL RESECTION OF PITUITARY ADENOMA: INITIAL EXPERIENCE OF A SINGLE NIGERIAN CENTER.垂体腺瘤经鼻内镜经蝶窦切除术的麻醉：尼日利亚单一中心的初步经验。
Ann Ib Postgrad Med. 2024 Aug 30;22(2):88-94.
2
miR-21-5p Targets PIK3R1 to Regulate the NF-B Signaling Pathway, Inhibiting the Invasion and Progression of Prolactinoma.微小RNA-21-5p靶向磷脂酰肌醇-3激酶调节亚基1以调控核因子-κB信号通路，抑制催乳素瘤的侵袭与进展。
Int J Endocrinol. 2025 Feb 5;2025:7741091. doi: 10.1155/ije/7741091. eCollection 2025.
3
Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas.微泌乳素瘤一线手术长期良好预后的预测因素
J Neurooncol. 2025 May;172(3):613-623. doi: 10.1007/s11060-025-04958-6. Epub 2025 Feb 4.
4
Microvascular Changes in Pituitary Adenoma Correlate with Structural Measurements and Visual Field Loss.垂体腺瘤的微血管变化与结构测量及视野缺损相关。
Neuropsychiatr Dis Treat. 2023 Dec 6;19:2745-2754. doi: 10.2147/NDT.S425454. eCollection 2023.
5
Isolated Neuropsychiatric Features with Non-functioning Pituitary Adenoma: Association or Coincidence?无功能垂体腺瘤的孤立性神经精神特征：关联还是巧合？
J Pediatr Neurosci. 2021 Oct-Dec;16(4):315-318. doi: 10.4103/jpn.JPN_197_20. Epub 2021 Jul 19.
6
Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas.机器学习在催乳素腺瘤一线手术结局预测中的应用。
Front Endocrinol (Lausanne). 2022 Feb 16;13:810219. doi: 10.3389/fendo.2022.810219. eCollection 2022.
7
A link between migraine and prolactin: the way forward.偏头痛与催乳素之间的联系：未来的方向。
Future Sci OA. 2021 Sep 22;7(9):FSO748. doi: 10.2144/fsoa-2021-0047. eCollection 2021 Oct.
8
Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term.原发性药物或手术治疗对催乳素瘤患者长期体重指数和代谢状况的影响。
J Clin Transl Endocrinol. 2021 Jun 17;24:100258. doi: 10.1016/j.jcte.2021.100258. eCollection 2021 Mar.
9
Ocular symptoms as the initial clinical manifestations in patients with extraocular tumors.眼外肿瘤患者以眼部症状为首发临床表现。
Ann Transl Med. 2021 Mar;9(6):497. doi: 10.21037/atm-21-830.
10
First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.一线手术治疗泌乳素瘤：来自三级转诊中心长期随访研究的经验。
J Endocrinol Invest. 2021 Dec;44(12):2621-2633. doi: 10.1007/s40618-021-01569-6. Epub 2021 Apr 13.
本文引用的文献
1
Lymphocytic hypophysitis: a rare or underestimated disease?淋巴细胞性垂体炎：一种罕见或被低估的疾病？
Eur J Endocrinol. 2003 Nov;149(5):363-76. doi: 10.1530/eje.0.1490363.
2
Current status and future opportunities for controlling acromegaly.肢端肥大症控制的现状与未来机遇
Pituitary. 2002;5(3):185-96. doi: 10.1023/a:1023369317275.
3
Molecular defects in the pathogenesis of pituitary tumours.垂体肿瘤发病机制中的分子缺陷
Front Neuroendocrinol. 2003 Apr;24(2):94-127. doi: 10.1016/s0091-3022(03)00012-8.
4
Medical management of growth hormone-secreting pituitary adenomas.生长激素分泌型垂体腺瘤的医学管理
Pituitary. 2002;5(2):67-76. doi: 10.1023/a:1022356313153.
5
Pegvisomant: an advance in clinical efficacy in acromegaly.培维索孟：肢端肥大症临床疗效的一项进展。
Eur J Endocrinol. 2003 Apr;148 Suppl 2:S27-32. doi: 10.1530/eje.0.148s027.
6
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.六项用于诊断成人生长激素缺乏症的检测方法的敏感性和特异性。
J Clin Endocrinol Metab. 2002 May;87(5):2067-79. doi: 10.1210/jcem.87.5.8509.
7
Stereotactic radiosurgery for pituitary adenomas.垂体腺瘤的立体定向放射外科治疗
Trends Endocrinol Metab. 2000 May-Jun;11(4):132-7. doi: 10.1016/s1043-2760(00)00242-3.
8
Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.库欣综合征的诊断与管理：一项意大利多中心研究的结果。意大利内分泌学会下丘脑 - 垂体 - 肾上腺轴病理生理学研究组
J Clin Endocrinol Metab. 1999 Feb;84(2):440-8. doi: 10.1210/jcem.84.2.5465.
9
Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.肢端肥大症的死亡率和癌症发病率：一项回顾性队列研究。英国肢端肥大症研究小组。
J Clin Endocrinol Metab. 1998 Aug;83(8):2730-4. doi: 10.1210/jcem.83.8.5007.
Zotero 插件